Delivery Order SPE2DB22D2006-SPE2DB24FV9KT
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation and a leading global pharmaceutical distributor. The contract, valued at $1,163.38, is for the delivery of HYSINGLA ER 60 MG TABLET 60S, a specialty pharmaceutical product. This order falls under a larger $999,999,999.00 indefinite delivery contract that AmerisourceBergen Drug Corp holds with DLA to provide a...
- The Defense Logistics Agency awarded a delivery order valued at $1,628.83 to AmerisourceBergen Drug Corp for HYSINGLA ER 40 mg tablets (60-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of 4568732359 - HYSINGLA ER 40 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,314.08. The contract is a firm fixed price delivery order with a completion date of July 9, 2025. Amerisourcebergen Drug Corp is registered in the System for Award Management (SAM) and is designated as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,182.07 to AmerisourceBergen Drug Corp for Hysingla ER 40 mg tablets (60-count package) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Hysingla ER is an extended-release opioid analgesic used for chronic pain...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDXY7, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,105.69, is for the delivery of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 7, 2025 and was awarded on February 6, 2025. It is a Firm Fixed Price contract with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hysingla ER 40 mg tablets (60-count units) with a ceiling value of $1,362.27. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a competitively awarded non-set-aside contract. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,887.98 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Hysingla ER 20 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,504.08 to AmerisourceBergen Drug Corp for the supply of Hysingla ER 20 mg tablets (60-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 80 mg Hysingla ER tablets, with a ceiling value of $1,531.57. The contract, which is not set-aside and employs firm fixed-price terms, was awarded on December 31, 2025, with an ultimate completion date of January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.60 to AmerisourceBergen Drug Corp for the supply of Hysingla ER 40 mg tablets (60-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This is a firm fixed-price, non-set-aside award executed at the vendor's Conshohocken, Pennsylvania location. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with...